Vectorite Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '26 Apr 17, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	643	635	935	621	621	492
Market Cap Growth	6.52%	-32.08%	50.46%	-	26.25%	-21.38%
Enterprise Value	468	442	728	396	375	526
Last Close Price	14.70	14.50	21.35	14.01	14.01	14.01
PE Ratio	-	-	-	-	74.32	-
PS Ratio	9.48	10.99	16.73	14.47	21.59	20.05
PB Ratio	1.64	1.63	2.17	1.41	1.33	1.43
P/TBV Ratio	1.66	1.66	2.29	1.49	1.40	1.56
P/FCF Ratio	-	-	-	44.96	-	-
P/OCF Ratio	-	-	719.97	42.25	-	-
EV/Sales Ratio	6.89	7.65	13.04	9.23	13.03	21.44
EV/FCF Ratio	-46.05	-	-	28.67	-	-
Net Debt / Equity Ratio	-0.45	-0.47	-0.47	-0.48	-0.51	-0.26
Net Debt / EBITDA Ratio	18.33	10.74	29.21	9.85	9.23	2.10
Net Debt / FCF Ratio	17.36	12.88	58.92	-15.46	3.54	2.38
Asset Turnover	0.16	0.13	0.12	0.09	0.07	0.07
Inventory Turnover	2.59	3.29	5.31	6.99	4.97	3.72
Quick Ratio	12.20	12.91	16.45	14.10	14.53	6.28
Current Ratio	13.46	14.06	17.53	14.93	15.07	6.74
Return on Equity (ROE)	-5.73%	-9.77%	-1.52%	-5.83%	2.05%	-20.93%
Return on Assets (ROA)	-2.65%	-3.75%	-2.20%	-3.98%	-6.15%	-10.05%
Return on Invested Capital (ROIC)	-8.34%	-12.03%	-7.09%	-13.41%	-17.57%	-24.34%
Return on Capital Employed (ROCE)	-4.50%	-6.50%	-3.70%	-6.80%	-8.90%	-17.20%
Earnings Yield	-3.60%	-6.31%	-0.71%	-4.25%	1.35%	-13.86%
FCF Yield	-1.58%	-2.26%	-0.37%	2.22%	-10.88%	-7.66%
Buyback Yield / Dilution	0.14%	0.14%	-	-1.84%	-47.01%	-14.34%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.